Acción A185750 CHONG KUN DANG PHARMACEUTICAL CORP.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Chong Kun Dang Pharmaceutical Corp.

Acciones

A185750

KR7185750007

Precio de cierre Korea S.E.
Otros sitios de cotización
 00:00:00 10/05/2024 		Varia. Cinco días. Varia. 1 de enero.
103.200 KRW +0,58 % Gráfico intradía de Chong Kun Dang Pharmaceutical Corp. -0,29 % -21,16 %
23/01 Chong Kun Dang Pharmaceutical Corp. (KOSE:A185750) anuncia una recompra de acciones por valor de 15.000 millones de KRW. CI
23/01 Chong Kun Dang Pharmaceutical Corp. autoriza un plan de recompra. CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on January 23, 2024.
Chong Kun Dang Pharmaceutical Corp. announces an Equity Buyback for KRW 15,000 million worth of its shares.
Chong Kun Dang Pharmaceutical Corp. authorizes a Buyback Plan.
Chong Kun Dang Pharmaceutical Inks Largest-Ever Technology Transfer Agreement with Novartis
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 13, 2022.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 13, 2022.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 13, 2022.
Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback announced on October 13, 2022, has expired with 62,127 shares, representing 0.51% for KRW 4,856.39 million.
Chong Kun Dang Pharmaceutical Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on February 10, 2022.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on February 10, 2022.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on February 10, 2022.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on February 10, 2022.
Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback announced on February 10, 2022, has expired with 109,064 shares, representing 0.89% for KRW 9,895.01 million.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 13, 2022.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.
Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción A185750
  4. Noticias Chong Kun Dang Pharmaceutical Corp.
  5. Otros idiomas